Advance your neurodegeneration research with our broad antibody portfolio, ready-to-use ELISA, and cellular kits to develop new efficacious therapies.
CST application and therapeutic domain experts keep up with the latest research and new neurodegenerative disease treatment approaches to develop a broad portfolio of antibodies, ready-to-use kits, and custom services that could lead to new, more efficacious therapies. Download the Neurodegeneration Therapeutics Discovery brochure and learn about:
- Solutions for assay development
- Solutions across the drug development continuum
- Cellular targets in therapeutic development
- Cell characterisation markers.
Download Now
Asset 7: Neurodegeneration therapeutics discovery
PDF, Size 0 kb
